Ye Olivia Xu-Cai
Internal Medicine · Tulsa, OKNPI 1457314635
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 401 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,758 and has fallen 71.9% since, to $776 in 2023. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$817
- GSK$756
- Boehringer Ingelheim$721
- Lilly USA, LLC$581
- AstraZeneca$558
- Novo Nordisk$479
- plus $3K from 36 others
What the payments were for
- Food & beverage$7,28699%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$124
- JARDIANCE$124
- FARXIGA$123
- BREZTRI$117
- Saxenda$115
- QULIPTA$115
- EVENITY$111
- TRELEGY ELLIPTA$108
How this compares
$7,361 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 19 | $455 |
| Amlodipine Besylate | 15 | $117 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tulsa
- Jesse RichardsTulsa$279K
- Madhuri LadTulsa$173K
- Stacy ChronisterTulsa$163K
- Layth Al AttarTulsa$35K
- Gerard McNultyTulsa$27K
- Peter LantzTulsa$23K
- Sudip TripathyTulsa$21K
- John RuffingTulsa$21K
- Joseph ReeseTulsa$18K
- Mark GallesTulsa$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.